Clinical Scorecard: Evaluating the Necessity of Routine Preoperative Esophagogastroduodenoscopy in Bariatric Surgery: A Systematic Review and Meta-analysis of 10,685 Cases

At a Glance

Key Highlights

• European and Italian guidelines recommend routine p-EGD with biopsies before bariatric surgery; American guidelines recommend it only for symptomatic patients.
• Routine p-EGD may detect asymptomatic benign, premalignant, or malignant lesions and influence management, but its utility in asymptomatic patients is debated.
• Evidence shows low prevalence of clinically significant findings in asymptomatic patients, questioning the cost-effectiveness and necessity of routine p-EGD for all bariatric surgery candidates.

Guideline-Based Recommendations

Diagnosis

• European and Italian national recommendations advocate routine preoperative upper gastrointestinal endoscopy with biopsies.
• American Society for Metabolic & Bariatric Surgery recommends p-EGD only in patients with upper gastrointestinal symptoms.

Management

• p-EGD findings may alter surgical plans or medical therapy, especially in procedures like gastric banding or vertical banded gastroplasty.
• Selective p-EGD approach is suggested for asymptomatic patients due to low clinical relevance of most lesions found.

Monitoring & Follow-up

• Routine p-EGD may not predict or prevent postoperative complications effectively.
• Postoperative endoscopic access may be limited, supporting preoperative evaluation in some cases.

Risks

• Routine p-EGD exposes patients to an invasive procedure with minimal but potential risks.
• Overuse of p-EGD may strain healthcare resources and reduce quality of care.

Patient & Prescribing Data

Patients scheduled for bariatric surgery, both symptomatic and asymptomatic

Routine p-EGD detects abnormalities in a small percentage of asymptomatic patients, rarely altering management; symptomatic patients benefit more from targeted p-EGD.

Clinical Best Practices

• Consider routine p-EGD in patients with upper gastrointestinal symptoms prior to bariatric surgery.
• Use selective p-EGD screening for asymptomatic patients based on regional cancer prevalence and clinical judgment.
• Avoid routine p-EGD in all bariatric surgery candidates to reduce unnecessary invasive procedures and healthcare costs.
• Recognize that certain bariatric procedures may warrant more thorough preoperative endoscopic evaluation due to altered postoperative anatomy.

References

• European and Italian national recommendations on preoperative endoscopy
• American Society for Metabolic & Bariatric Surgery guidelines
• Systematic review on routine p-EGD utility in bariatric surgery